Combination antibiotic susceptibility testing to treat exacerbations of cystic fibrosis associated with multiresistant bacteria: a randomised, double-blind, controlled clinical trial.
Aaron SD, Vandemheen KL, Ferris W, Fergusson D, Tullis E, Haase D, Berthiaume Y, Brown N, Wilcox P, Yozghatlian V, Bye P, Bell S, Chan F, Rose B, Jeanneret A, Stephenson A, Noseworthy M, Freitag A, Paterson N, Doucette S, Harbour C, Ruel M, MacDonald N.
Aaron SD, et al. Among authors: bell s.
Lancet. 2005 Aug 6-12;366(9484):463-71. doi: 10.1016/S0140-6736(05)67060-2.
Lancet. 2005.
PMID: 16084254
Clinical Trial.